(Q34094288)

31 July 2017

1 reference

title

Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders (English)

1 reference

31 July 2017

0 references

1 reference

King BH

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Journal of Autism and Developmental Disorders

31 July 2017

published in

1 reference

31 July 2017

volume

30

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

439-445

1 reference

Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis.

31 July 2017

cites work

1 reference

12 December 2020

Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation

1 reference

12 December 2020

Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation.

1 reference

12 December 2020

Pharmacologic control of pemoline induced self-injurious behavior in rats.

1 reference

12 December 2020

A dopamine deficiency model of Lesch-Nyhan disease--the neonatal-6-OHDA-lesioned rat.

1 reference

12 December 2020

Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation.

1 reference

12 December 2020

Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine

1 reference

12 December 2020

Pipamperone (Dipiperon, R3345) in troublesome mental retardates: a double-blind placebo controlled cross-over study with long-term follow-up

1 reference

12 December 2020

Severe behaviour problems associated with rapid cycling bipolar disorder in two adults with profound mental retardation

1 reference

12 December 2020

Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study

1 reference

12 December 2020

Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo

1 reference

12 December 2020

Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior

1 reference

12 December 2020

Catecholaminergic involvement in the control of aggression: hormones, the peripheral sympathetic, and central noradrenergic systems

1 reference

12 December 2020

Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group

1 reference

12 December 2020

Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients--a pilot study

1 reference

12 December 2020

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

1 reference

12 December 2020

Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior

1 reference

12 December 2020

Lithium in Non-Manic-Depressives: Antiaggressive Effect and Red Blood Cell Lithium Values

1 reference

12 December 2020

Pimozide in autistic children

1 reference

12 December 2020

GBR-12909-induced self-injurious behavior: role of dopamine

1 reference

12 December 2020

Haloperidol for psychiatric disorders in children.

1 reference

12 December 2020

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.

1 reference

12 December 2020

Naltrexone in autistic children: behavioral symptoms and attentional learning

1 reference

12 December 2020

Nonneuroleptic treatment of disruptive behavior in organic mental syndromes

1 reference

12 December 2020

Haloperidol in the Treatment of Behavioural Disorders in Children and Adolescents

1 reference

12 December 2020

Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients

1 reference

12 December 2020

Inhibition of fighting in isolated mice following repeated administration of lithium chloride

1 reference

12 December 2020

Psychopharmacology of self-injurious behavior in the mentally retarded

1 reference

12 December 2020

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

1 reference

12 December 2020

The serotonin system in autism

1 reference

12 December 2020

Neurotransmitters regulating feline aggressive behavior.

1 reference

12 December 2020

Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children

1 reference

12 December 2020

Piperacetazine (Quide) in the management of behavioral disorders in mildly retarded institutionalized boys

1 reference

12 December 2020

Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation

1 reference

12 December 2020

Effects of L-dopa in autism.

1 reference

12 December 2020

Treatment of mentally retarded with thioridazine

1 reference

12 December 2020

Use of methylphenidate in the treatment of children with autistic disorder.

1 reference

12 December 2020

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

12 December 2020

Risperidone in the treatment of pervasive developmental disorder.

1 reference

12 December 2020

Autism: the treatment of aggressive behaviors.

1 reference

12 December 2020

Clinical comparison of haloperidol with chlorpromazine in mentally retarded children

1 reference

12 December 2020

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism

1 reference

12 December 2020

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

12 December 2020

Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005555624566

1 reference

Dimensions Publication ID

31 July 2017

1006929432

0 references

1 reference